These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32706637)

  • 1. Preventing Graft-Versus-Host Disease Without Losing Graft-Versus-Leukemia Effect After Allogeneic Stem-Cell Transplantation.
    Kröger N
    J Clin Oncol; 2020 Oct; 38(29):3357-3360. PubMed ID: 32706637
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation.
    Modi D; Al-Kadhimi Z; Chen W; Jang H; Deol A; Ayash L; Bhutani D; Alavi A; Ratanatharathorn V; Uberti JP
    Am J Hematol; 2018 Aug; 93(4):E96-E98. PubMed ID: 29318650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Baron F; Mohty M; Blaise D; Socié G; Labopin M; Esteve J; Ciceri F; Giebel S; Gorin NC; Savani BN; Schmid C; Nagler A
    Haematologica; 2017 Feb; 102(2):224-234. PubMed ID: 27927772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Rubio MT; Labopin M; Blaise D; Socié G; Contreras RR; Chevallier P; Sanz MA; Vigouroux S; Huynh A; Shimoni A; Bulabois CE; Caminos N; López-Corral L; Nagler A; Mohty M
    Haematologica; 2015 May; 100(5):683-9. PubMed ID: 25769546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
    Radujkovic A; Guglielmi C; Bergantini S; Iacobelli S; van Biezen A; Milojkovic D; Gratwohl A; Schattenberg AV; Verdonck LF; Niederwieser DW; de Witte T; Kröger N; Olavarria E;
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1230-6. PubMed ID: 25797175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis.
    Robin M; Chevret S; Koster L; Wolschke C; Yakoub-Agha I; Bourhis JH; Chevallier P; Cornelissen JJ; Reményi P; Maertens J; Poiré X; Craddock C; Socié G; Itälä-Remes M; Schouten HC; Marchand T; Passweg J; Blaise D; Damaj G; Ozkurt ZN; Zuckerman T; Cluzeau T; Labussière-Wallet H; Cammenga J; McLornan D; Chalandon Y; Kröger N
    Haematologica; 2019 Jun; 104(6):1230-1236. PubMed ID: 30655365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short Course of Post-Transplantation Cyclophosphamide and Bortezomib for Graft-versus-Host Disease Prevention after Allogeneic Peripheral Blood Stem Cell Transplantation Is Feasible and Yields Favorable Results: A Phase I Study.
    Al-Homsi AS; Cole K; Bogema M; Duffner U; Williams S; Mageed A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1315-20. PubMed ID: 25765556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study.
    Bonifazi F; Solano C; Wolschke C; Sessa M; Patriarca F; Zallio F; Nagler A; Selleri C; Risitano AM; Messina G; Bethge W; Herrera P; Sureda A; Carella AM; Cimminiello M; Guidi S; Finke J; Sorasio R; Ferra C; Sierra J; Russo D; Benedetti E; Milone G; Benedetti F; Heinzelmann M; Pastore D; Jurado M; Terruzzi E; Narni F; Völp A; Ayuk F; Ruutu T; Kröger N
    Lancet Haematol; 2019 Feb; 6(2):e89-e99. PubMed ID: 30709437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes.
    Toor AA; Sabo RT; Roberts CH; Moore BL; Salman SR; Scalora AF; Aziz MT; Shubar Ali AS; Hall CE; Meier J; Thorn RM; Wang E; Song S; Miller K; Rizzo K; Clark WB; McCarty JM; Chung HM; Manjili MH; Neale MC
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1237-45. PubMed ID: 25849208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The graft-versus-neuroblastoma effect of allogeneic hematopoietic stem cell transplantation, a review of clinical and experimental evidence and a perspective on mechanisms.
    Willems L; Waer M; Billiau AD
    Pediatr Blood Cancer; 2014 Dec; 61(12):2151-7. PubMed ID: 25156335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.
    Nash RA; Storb R
    Curr Opin Immunol; 1996 Oct; 8(5):674-80. PubMed ID: 8902393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-versus-host disease: have we solved the problem?
    Giralt S
    J Clin Oncol; 2012 Sep; 30(26):3160-1. PubMed ID: 22869873
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.
    Inamoto Y; Kimura F; Kanda J; Sugita J; Ikegame K; Nakasone H; Nannya Y; Uchida N; Fukuda T; Yoshioka K; Ozawa Y; Kawano I; Atsuta Y; Kato K; Ichinohe T; Inoue M; Teshima T;
    Haematologica; 2016 Dec; 101(12):1592-1602. PubMed ID: 27662017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of the actions of antithymocyte globulin in patients undergoing allogeneic hematopoietic cell transplantation.
    Yuan J; Pei R; Su W; Cao J; Lu Y
    Oncotarget; 2017 Feb; 8(7):10871-10882. PubMed ID: 28107198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose alemtuzumab vs. standard policy for prevention of graft-versus-host disease in unrelated and related allogeneic stem cell transplantation-a matched pair analysis.
    Busemann C; Neumann T; Schulze M; Klenner A; Thiele T; Greinacher A; Dölken G; Krüger WH
    Ann Hematol; 2013 Jul; 92(7):945-52. PubMed ID: 23463451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive allogeneic immunotherapy--history and future perspectives.
    Schleuning M
    Transfus Sci; 2000 Oct; 23(2):133-50. PubMed ID: 11035275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-versus-host disease--from the bench to the bedside?
    Socié G
    N Engl J Med; 2005 Sep; 353(13):1396-7. PubMed ID: 16192485
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk-Adapted Approach to HLA-Matched Sibling Hematopoietic Cell Allografting: Impact of Adjusting Conditioning Intensity and Integrating Post-Transplant Therapeutic Interventions.
    El Cheikh J; Otrock ZK; Qannus AA; Kharfan-Dabaja MA; Bazarbachi A
    Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):304-10. PubMed ID: 26923326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years.
    Polverelli N; Malagola M; Turra A; Skert C; Perucca S; Chiarini M; Cattina F; Rambaldi B; Cancelli V; Morello E; Schieppati F; Bernardi S; Zanaglio C; Sottini A; Giustini V; Imberti L; Montanelli A; Russo D
    Leuk Lymphoma; 2018 Nov; 59(11):2700-2705. PubMed ID: 29527964
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment outcome of allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies not in remission].
    Bao HY; Wu XJ; Ma X
    Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):156-7. PubMed ID: 22780938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.